Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep
Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members of the management team bring expertis...
How might the upcoming data releases and regulatory engagements affect analyst coverage and consensus estimates for ONTX?
Will the key opinion leader event generate broader clinical adoption or reimbursement opportunities for Pelareorep?
What potential catalysts or risks could drive the stock price in the short term following this earnings release?
29 days ago